Company
Novo Holdings
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Claris Biotherapeutics, Inc. | Series B | 2026-08-03 | |
| Alveus Therapeutics Inc. | Series A | 2026-03-02 | |
| Expedition Therapeutics | Series A | 2025-10-10 | Lead |
| Crystalys Therapeutics | Series A | 2025-09-30 | Lead |
| Glycomine | Series C | 2025-04-16 | |
| SiteOne Therapeutics | Series C | 2024-12-18 | Lead |
| Kivu Bioscience | Series A Funding | 2024-10-28 | Lead |
| AvenCell | Series B Funding | 2024-10-22 | Lead |
| Route 92 Medical | Series F Extension Equity Financing | 2024-09-24 | Lead |
| Bluejay Therapeutics | series c | 2024-05-09 | |
| Clasp Therapeutics | Financing | 2024-03-20 | Lead |
| Nalu Medical | Series E Funding | 2024-03-06 | Lead |
| MapLight Therapeutics | Series C Funding | 2023-10-30 | Lead |
| Octave | Series C Funding | 2023-06-16 | Lead |